Skip to content

Stimulation Galvanique Vestibulaire

Galvanic Vestibular Stimulation : Role in the Improvement of Egocentric Frame in Patient With Right Parietal Lobe Lesions

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02201927
Acronym
GVS
Enrollment
16
Registered
2014-07-28
Start date
2014-04-30
Completion date
2014-10-31
Last updated
2015-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Hemorrhage of Right Parietal Lobe

Keywords

galvanic vestibular stimulation, right parietal lobe lesion, egocentric space

Brief summary

Right posterior parietal cortex is involved in spatial cognition. Blindfolded patients suffering right posterior parietal lesions fail to update their own position after a body rotation. Right cathodal galvanic vestibular stimulation activates right posterior parietal cortex and reduces symptoms of spatial neglect, another disability frequently encountered after right posterior parietal lesion. The aims of this study are to confirm posterior parietal involvement in automatic updating of body-centered spatial relationships and to evaluate therapeutic effects of galvanic vestibular stimulation. Performances of three groups of adults are compared before and during galvanic vestibular stimulation on a pointing task: a healthy control group, a brain-injured control group with stroke lesions sparing right posterior parietal cortex and a group of stroke patients with right posterior parietal lesions.

Interventions

Sponsors

University of Versailles
CollaboratorOTHER
Centre d'Investigation Clinique et Technologique 805
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* patient with right posterieur parietal lobe lesion * patient with cerebral vascular stroke * healthy volonteers Age greater than or equal to 18 written informed consent

Exclusion criteria

* patient's refusal to participate to the study * inability to cooperate * cognitive trouble * epilepsy

Design outcomes

Primary

MeasureTime frameDescription
deviation from target score30 mindifference in degree between the actual and target score

Secondary

MeasureTime frameDescription
deviation from target straight ahead30mindifference in degree between the actual straight ahead and target score
deviation rightward line bisection30minpercentage difference between actual and target score on test deviation right line bisection

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026